Symbio is a specialty contract research organization (CRO) running global clinical trials for dermatology, aesthetics, gastroenterology, and inflammatory diseases. With more than 25 years of therapeutic expertise, the company combines a 5,000-plus-site network across 50 countries with stable teams—45% of its staff have worked together for more than 15 years. Through subsidiary Dow Development Laboratories, Symbio also connects clinical research with topical drug formulation and manufacturing in a 23,000-square-foot FDA-registered, cGMP-compliant facility.
FDA-registered facility
registration
Current Good Manufacturing Practice (cGMP) compliant
compliance_program
German commercial registration HRB 11208
registration
ICON plcFounded in Dublin in 1990 by a team of five, ICON plc has grown into a clinical research organisation providing outsourced drug and medical-device development and commercialisation services. Its nearly 40,000 employees work across 80 locations in more than 40 countries, supporting studies from early development through post-marketing, with particular strength in integrated clinical research and small-batch manufacturing for early-phase trials. ICON also brings locally based regulatory and project-management expertise to markets such as Japan, India and China.DAYTON, OH
Curia Global, IncFounded in Albany in 1991 as Albany Molecular Research, Curia is a global contract research, development and manufacturing organization serving pharmaceutical and biotechnology companies from drug discovery through commercial production. The company now operates an integrated network of more than 20 facilities across North America, Europe and India, with more than 3,000 professionals supporting small-molecule and biologics programs. Curia’s history includes discovery and development of the active pharmaceutical ingredient in Allegra and deep experience scaling complex APIs, sterile drug products and biologics.ALBANY, NY
TRPL LLCBuilt around deep transdermal-drug-delivery expertise, TRPL LLC is a contract research laboratory developing and testing customized drug-delivery systems and products for pharmaceutical, over-the-counter, cosmeceutical, and nutraceutical companies. Its New York and New Jersey laboratories support formulation and product development, with particular strength in in-vitro percutaneous absorption studies and in-vivo models. The scientific team brings more than 75 years of combined experience, including leadership from a former Long Island University pharmaceutical-sciences professor who authored more than 100 research papers.PARAMUS, NJ
Pharmaceutics International, Inc. (Pii)Founded in 1994, Pharmaceutics International, Inc. (Pii) is a Hunt Valley drug product contract development and manufacturing organization that takes pharmaceutical products from early development through clinical trials and commercial production. Now part of Jabil, Pii combines more than 30 years of complex-formulation experience with a 360,000-square-foot, four-site campus and more than 300 scientists and support staff. Its GMP facilities are built for demanding work, including potent compounds, complex injectables and oral drug products, with FDA-licensed and DEA-registered operations.HUNT VALLEY, MD